Literature DB >> 32387052

Surgical Techniques for the Subretinal Delivery of Pediatric Gene Therapy.

Kenneth C Fan1, Nicolas A Yannuzzi1, Nimesh A Patel1, Catherin I Negron1, Robert A Sisk2, Aaron Nagiel3, Audina M Berrocal4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32387052      PMCID： PMC7313618          DOI： 10.1016/j.oret.2020.01.023

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN： 2468-6530


× No keyword cloud information.
  7 in total

1.  Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.

Authors:  Stephen Russell; Jean Bennett; Jennifer A Wellman; Daniel C Chung; Zi-Fan Yu; Amy Tillman; Janet Wittes; Julie Pappas; Okan Elci; Sarah McCague; Dominique Cross; Kathleen A Marshall; Jean Walshire; Taylor L Kehoe; Hannah Reichert; Maria Davis; Leslie Raffini; Lindsey A George; F Parker Hudson; Laura Dingfield; Xiaosong Zhu; Julia A Haller; Elliott H Sohn; Vinit B Mahajan; Wanda Pfeifer; Michelle Weckmann; Chris Johnson; Dina Gewaily; Arlene Drack; Edwin Stone; Katie Wachtel; Francesca Simonelli; Bart P Leroy; J Fraser Wright; Katherine A High; Albert M Maguire
Journal:  Lancet       Date:  2017-07-14       Impact factor: 79.321

2.  Intraoperative Use of Microscope-Integrated Optical Coherence Tomography for Subretinal Gene Therapy Delivery.

Authors:  Ninel Z Gregori; Byron L Lam; Janet L Davis
Journal:  Retina       Date:  2019-10       Impact factor: 4.256

Review 3.  Gene therapy for inherited retinal degenerations: initial successes and future challenges.

Authors:  Priya R Gupta; Rachel M Huckfeldt
Journal:  J Neural Eng       Date:  2017-08-22       Impact factor: 5.379

Review 4.  Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.

Authors:  Tuyen Ong; Mark E Pennesi; David G Birch; Byron L Lam; Stephen H Tsang
Journal:  Pharm Res       Date:  2019-01-07       Impact factor: 4.200

5.  Technique of retinal gene therapy: delivery of viral vector into the subretinal space.

Authors:  K Xue; M Groppe; A P Salvetti; R E MacLaren
Journal:  Eye (Lond)       Date:  2017-08-18       Impact factor: 3.775

Review 6.  Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials.

Authors:  G Alex Ochakovski; K Ulrich Bartz-Schmidt; M Dominik Fischer
Journal:  Front Neurosci       Date:  2017-04-03       Impact factor: 4.677

7.  Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results.

Authors:  Byron L Lam; Janet L Davis; Ninel Z Gregori; Robert E MacLaren; Aniz Girach; Jennifer D Verriotto; Belen Rodriguez; Potyra R Rosa; Xiaojun Zhang; William J Feuer
Journal:  Am J Ophthalmol       Date:  2018-09-19       Impact factor: 5.258
  7 in total
  2 in total

Review 1.  Subretinal Injection Techniques for Retinal Disease: A Review.

Authors:  Cristina Irigoyen; Asier Amenabar Alonso; Jorge Sanchez-Molina; María Rodríguez-Hidalgo; Araceli Lara-López; Javier Ruiz-Ederra
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

Review 2.  Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.

Authors:  Yan Nuzbrokh; Alexis S Kassotis; Sara D Ragi; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmol Ther       Date:  2020-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.